{
    "organizations": [],
    "uuid": "78a365e564f5401f733cf8d01fa1feb4257d1cab",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-karessa-result-shows-expected-plas/brief-karessa-result-shows-expected-plasma-levels-were-achieved-idUSFWN1R901F",
    "ord_in_thread": 0,
    "title": "BRIEF-Karessa: Result Shows Expected Plasma Levels Were Achieved‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 27 (Reuters) - KARESSA PHARMA HOLDING AB (PUBL) :\n* RESULT SHOWS EXPECTED PLASMA LEVELS WERE ACHIEVED‍​ * NO UNEXPECTED SIDE EFFECTS WERE REPORTED DURING CLINICAL STUDY Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-27T14:39:00.000+03:00",
    "crawled": "2018-03-28T19:03:32.007+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "karessa",
        "pharma",
        "holding",
        "ab",
        "publ",
        "result",
        "show",
        "expected",
        "plasma",
        "level",
        "unexpected",
        "side",
        "effect",
        "reported",
        "clinical",
        "study",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}